Pfizer bids higher for AstraZeneca
MLex Summary: Pharmaceutical giant Pfizer said Friday that it submitted a higher bid to buy rival AstraZeneca. Under the revised proposal, Pfizer would pay $84.47 per AstraZeneca share, based on Pfizer’s closing share price of $31.15 on...To view the full article, register now.
Already a subscriber? Click here to view full article